| __timestamp | HUTCHMED (China) Limited | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19764000 | 3068000000 |
| Thursday, January 1, 2015 | 67426000 | 3027000000 |
| Friday, January 1, 2016 | 59752000 | 3222000000 |
| Sunday, January 1, 2017 | 65383000 | 3532000000 |
| Monday, January 1, 2018 | 70165000 | 3914000000 |
| Tuesday, January 1, 2019 | 44738000 | 4268000000 |
| Wednesday, January 1, 2020 | 39457000 | 4618000000 |
| Friday, January 1, 2021 | 97894000 | 5473000000 |
| Saturday, January 1, 2022 | 115306000 | 5626000000 |
| Sunday, January 1, 2023 | 453552000 | 5834000000 |
| Monday, January 1, 2024 | 6537000000 |
Cracking the code
In the ever-evolving landscape of the pharmaceutical industry, the financial performance of companies can offer profound insights into their strategic positioning and market dynamics. Over the past decade, Zoetis Inc. and HUTCHMED (China) Limited have showcased contrasting trajectories in gross profit.
Since 2014, Zoetis Inc. has demonstrated a robust growth pattern, with its gross profit surging by nearly 90%, reaching approximately $5.8 billion in 2023. This consistent upward trend underscores Zoetis's strong market presence and strategic initiatives in the animal health sector.
Conversely, HUTCHMED (China) Limited experienced a more volatile journey. Despite a significant leap in 2023, with gross profit peaking at $453 million, the company's growth has been less predictable, reflecting the challenges and opportunities within the Chinese pharmaceutical market.
Gross Profit Analysis: Comparing Novartis AG and Zoetis Inc.
Gross Profit Analysis: Comparing Pfizer Inc. and HUTCHMED (China) Limited
Key Insights on Gross Profit: Zoetis Inc. vs Lantheus Holdings, Inc.
Gross Profit Analysis: Comparing Zoetis Inc. and Vericel Corporation
Gross Profit Trends Compared: Zoetis Inc. vs Taro Pharmaceutical Industries Ltd.
Zoetis Inc. vs Amphastar Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Genmab A/S and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Alkermes plc vs HUTCHMED (China) Limited
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Gross Profit Comparison: Vericel Corporation and HUTCHMED (China) Limited Trends
Who Generates Higher Gross Profit? HUTCHMED (China) Limited or Ligand Pharmaceuticals Incorporated
Gross Profit Analysis: Comparing HUTCHMED (China) Limited and MiMedx Group, Inc.